EKSO:NASDAQ
Ekso Bionics Holdings Inc
11,79 $
arrow_downward
−1,83%(−0,22) 1 p
1. mai, 16:00:01 GMT −4 · USD
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse EKSO põhistatistika genereerimine…
Ava
12,26 $
Kõrge
12,31 $
Madal
10,98 $
Turu kapit.
42,01 mln
Maht
40,00
52 näd kõrgeim
13,50 $
52 näd madalaim
2,73 $
Aktsiatulu
−4,91 $
Beeta
0,86
Käibivad aktsiad
3,56 mln
Töötajate arv
50
Uudised
Erinevatest veebiallikatest
Profiil
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Teave üksuse Ekso Bionics Holdings Inc kohta
TegevjuhtScott Davis
Töötajad50
Asutatud2005
PeakontoridSan Rafael, California, Ameerika Ühendriigid
Sektor-
Veebisaiteksobionics.com
AI genereeritud sisu võib sisaldada vigu. Lisateave